311 results Stibbe advises on the notes offerings of Fiat Chrysler Advising J.P. Morgan and the other underwriters on the notes offerings of Fiat Chrysler Automobiles N.V. for a total amount of USD 3.0 billion. Stibbe advises on the equity offering of Fiat Chrysler Stibbe advises J.P. Morgan and the other underwriters on the equity offering of Fiat Chrysler Automobiles N.V. Stibbe advises Tessenderlo Chemie Stibbe advised Euronext Brussels’ listed Tessenderlo Chemie NV on its EUR 175 million rights’ offering and capital increase, backed by its reference shareholder Picanol NV. Stibbe advises on the convertible bond offering of NXP Semiconductors Advising the underwriters on the USD 1 billion convertible bond offering of NXP Semiconductors Stibbe advises Tornier Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion. Stibbe advises on the IPO of Pershing Square Holdings Stibbe advises Pershing Square Holdings, Ltd. on the IPO of this investment fund managed by the leading active investor Bill Ackmann. Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business. Stibbe advises listed German group Stibbe advised on the tax aspects of a listed German group's debt restructuring through a Luxembourg vehicle. Stibbe advises on the IPO of ING US INC Advising the Dutch financial group ING on the USD 1.27 billion initial public offering and USD 900 million secondary offering by its New York-based US insurance unit, ING US Inc. Stibbe advises leading pharmaceutical company Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients. Stibbe advises the French state Stibbe advises Canon Advising Canon in connection with their dispute with the State of the Netherlands on the procurement of framework contracts. Case won up to and including the Supreme Court. Stibbe advises on the IPO of Yandex Stibbe advises Syngenta Stibbe assisted Syngenta Crop Protection AG in its successful public voluntary take-over bid on all outstanding securities of Devgen NV. Aan de slag met de nieuwe Wet hergebruik van overheidsinformatie Op 18 juli 2015 is de Wet hergebruik van overheidsinformatie (de "Who") in werking getreden. Burgers en bedrijven kunnen bij publieketaakinstellingen een verzoek indienen tot het verstrekken van overheidsinformatie. Charlotte Oskam Associate Amsterdam Product counseling en intellectueel eigendom In deze podcastaflevering van Stibbe Legal Insights spreken Femke van der Voort, gespecialiseerd in intellectueel eigendom, en Paul van der Hulst, mede-eigenaar en managing director van MoviĜo, over het beschermen van intellectuele eigendomsrechten. SPACs en De-SPACs – een update naar aanleiding van de SPAC-hausse In 2018 werd sinds lange tijd weer een SPAC genoteerd aan Euronext Amsterdam. Hierop volgde een SPAC-hausse: sinds eind 2020 zijn 18 SPACs zijn genoteerd aan Euronext Amsterdam. Pagination Previous page Page 13 Current page 14 Page 15 Page 16 Next page
Stibbe advises on the notes offerings of Fiat Chrysler Advising J.P. Morgan and the other underwriters on the notes offerings of Fiat Chrysler Automobiles N.V. for a total amount of USD 3.0 billion.
Stibbe advises on the equity offering of Fiat Chrysler Stibbe advises J.P. Morgan and the other underwriters on the equity offering of Fiat Chrysler Automobiles N.V.
Stibbe advises Tessenderlo Chemie Stibbe advised Euronext Brussels’ listed Tessenderlo Chemie NV on its EUR 175 million rights’ offering and capital increase, backed by its reference shareholder Picanol NV.
Stibbe advises on the convertible bond offering of NXP Semiconductors Advising the underwriters on the USD 1 billion convertible bond offering of NXP Semiconductors
Stibbe advises Tornier Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion.
Stibbe advises on the IPO of Pershing Square Holdings Stibbe advises Pershing Square Holdings, Ltd. on the IPO of this investment fund managed by the leading active investor Bill Ackmann.
Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.
Stibbe advises listed German group Stibbe advised on the tax aspects of a listed German group's debt restructuring through a Luxembourg vehicle.
Stibbe advises on the IPO of ING US INC Advising the Dutch financial group ING on the USD 1.27 billion initial public offering and USD 900 million secondary offering by its New York-based US insurance unit, ING US Inc.
Stibbe advises leading pharmaceutical company Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.
Stibbe advises Canon Advising Canon in connection with their dispute with the State of the Netherlands on the procurement of framework contracts. Case won up to and including the Supreme Court.
Stibbe advises Syngenta Stibbe assisted Syngenta Crop Protection AG in its successful public voluntary take-over bid on all outstanding securities of Devgen NV.
Aan de slag met de nieuwe Wet hergebruik van overheidsinformatie Op 18 juli 2015 is de Wet hergebruik van overheidsinformatie (de "Who") in werking getreden. Burgers en bedrijven kunnen bij publieketaakinstellingen een verzoek indienen tot het verstrekken van overheidsinformatie.
Product counseling en intellectueel eigendom In deze podcastaflevering van Stibbe Legal Insights spreken Femke van der Voort, gespecialiseerd in intellectueel eigendom, en Paul van der Hulst, mede-eigenaar en managing director van MoviĜo, over het beschermen van intellectuele eigendomsrechten.
SPACs en De-SPACs – een update naar aanleiding van de SPAC-hausse In 2018 werd sinds lange tijd weer een SPAC genoteerd aan Euronext Amsterdam. Hierop volgde een SPAC-hausse: sinds eind 2020 zijn 18 SPACs zijn genoteerd aan Euronext Amsterdam.